Politiparty
Politiparty
LeaderboardCongressBills

118th Congress Health

H.R. 1613: Drug Price Transparency in Medicaid Act of 2023

Introduced

  1. Introduced (completed)Mar 17, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Mar 17, 2023

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

37

Bipartisan support.

Who scored on this bill

12 points earned
  1. 1Earl Carter R-GA SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Earl Carter

History

  1. Mar 17, 2023Introduced in the House by Earl Carter.
Show the full action history (3 actions)
  1. Mar 24, 2023Referred to the Subcommittee on Health.
  2. Mar 17, 2023Introduced in House
  3. Mar 17, 2023Referred to the House Committee on Energy and Commerce.